InsidersTradesSigma
Total declarations
Company
▲ Purchases (6 ops.)
▼ Sales (0 ops.)
Insider track record
CFODisclosed buys
6
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-27.8%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the full record of transactions filed by Morris Gabriel S, Chief Financial Officer. Director active across 1 company, notably Immix Biopharma, Inc.. Aggregated, 9 reports have been logged. Split: 6 buys · 0 sell. Total volume traded: €33k. Activity tracked since 20 December 2021. The latest transaction was filed on 8 December 2025 (X). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Morris Gabriel S
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations9 total
156,000 shares@ US$0.8054.6% of flowCommon StockSEC:0001493152-25-027107:0
2,600 shares@ US$1.974.8% of flowCommon StockSEC:0001493152-25-013918:0
Canonical exit: 15 Dec 2025 (T+90)
2,225 shares@ US$2.2795.2% of flowCommon StockSEC:0001641172-25-015755:0
Canonical exit: 16 Sept 2025 (T+90)
2,500 shares@ US$2.11923.6% of flowCommon StockSEC:0001493152-24-023288:0
Canonical exit: 5 Sept 2024 (T+90)
3,300 shares@ US$1.80994.0% of flowCommon StockSEC:0001493152-24-022654:0
Canonical exit: 2 Sept 2024 (T+90)
194,218 sharesCommon StockSEC:0001493152-24-020776:0
4,500 shares@ US$2.23156.8% of flowCommon StockSEC:0001493152-24-019368:0
Canonical exit: 12 Aug 2024 (T+90)
5,200 shares@ US$0.943.5% of flowCommon StockSEC:0001493152-22-032555:0
Canonical exit: 12 Feb 2023 (T+90)
74,116 shares@ US$0.850.010% mcap50.0% of flowCommon StockSEC:0001493152-21-032035:0
9 of 9 declarations
About Morris Gabriel S
Gabriel S. Morris is the Chief Financial Officer of Immix Biopharma, Inc. He is responsible for the financial management of the company, overseeing accounting and financial operations to ensure compliance and financial health.
